GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Insider Ownership

J.Molner AS (OTSE:MOLNR) Insider Ownership : 0.00 % (As of Jun. 03, 2024)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, J.Molner AS's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, J.Molner AS's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, J.Molner AS's Float Percentage Of Total Shares Outstanding is 0.00%.


J.Molner AS Insider Ownership Historical Data

The historical data trend for J.Molner AS's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Insider Ownership Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Insider Ownership
- - -

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Insider Ownership - - - - -

J.Molner AS Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines